A Clinician’s Comments on Cancer Therapy with Lymphocytes
Immunotherapy in oncology is not as convenient a method, and does not solve as many problems, as was originally hoped. However, every clinician is loudly demanding improved techniques of therapy. The clinician has to evaluate any potential therapy; he or she is responsible for its effect and must find a proper balance between benefits and risks. Immunotherapy in its current guise, with biological response modifiers, cytokines, monoclonal antibodies, and autologous lymphocytes, is a promising weapon in the therapeutic armamentarium of oncology.